Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1897 1
1940 1
1946 1
1947 2
1950 1
1951 2
1953 1
1954 4
1955 2
1956 1
1957 2
1958 1
1959 2
1960 1
1961 4
1962 3
1963 4
1964 5
1965 3
1966 2
1967 5
1968 7
1969 7
1970 4
1971 13
1972 10
1973 9
1974 16
1975 27
1976 34
1977 14
1978 14
1979 20
1980 15
1981 22
1982 47
1983 37
1984 37
1985 37
1986 61
1987 43
1988 47
1989 52
1990 70
1991 52
1992 68
1993 49
1994 46
1995 47
1996 54
1997 60
1998 71
1999 81
2000 122
2001 131
2002 134
2003 158
2004 201
2005 196
2006 207
2007 257
2008 271
2009 291
2010 332
2011 330
2012 417
2013 452
2014 672
2015 721
2016 821
2017 839
2018 995
2019 1221
2020 1413
2021 1555
2022 1778
2023 1482
2024 1363
2025 1518
2026 1074
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,776 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Syahirbanun
Page 1
Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial.
Manier S, Dimopoulos MA, Leleu XP, Moreau P, Cavo M, Goldschmidt H, Orlowski RZ, Tron M, Tekle C, Brégeault MF, Shafer AT, Beksac M, Facon T. Manier S, et al. Haematologica. 2025 Sep 1;110(9):2139-2150. doi: 10.3324/haematol.2024.287200. Epub 2025 Mar 20. Haematologica. 2025. PMID: 40109195 Free PMC article. Clinical Trial.
All patients received standard VRd/Rd dosing; Isa-VRd patients received intravenous Isa (cycle 1, 10 mg/kg once weekly; cycles 2-17, once every 2 weeks; subsequent cycles, once every 4 weeks). ...Using this scoring, 26.7% of patients were frail (26.0% Isa-VRd …
All patients received standard VRd/Rd dosing; Isa-VRd patients received intravenous Isa (cycle 1, 10 mg/kg once weekly; cycles …
Voclosporin.
[No authors listed] [No authors listed] 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 34699156 Free Books & Documents. Review.
Isatuximab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma: dynamics of MRD negativity in the IMROZ study.
Orlowski RZ, Dimopoulos MA, Leleu X, Facon T, Ishida T, Hájek R, Špička I, Romejko-Jarosinska J, Vorobyev V, Besemer B, Beşışık SK, Robak P, Jelinek T, Goldschmidt H, Martin T, Mohty M, Macé S, Kodas E, Tekle C, Shafer AT, Moreau P. Orlowski RZ, et al. Blood. 2026 Jun 4;147(23):2760-2769. doi: 10.1182/blood.2025030120. Blood. 2026. PMID: 41758929 Free PMC article. Clinical Trial.
Benefit with Isa-VRd/Isa-Rd was observed across key patient subgroups, including older (>70 years) and frail patients. Time to progression (TTP) was significantly prolonged with Isa-VRd/Isa-Rd vs VRd/Rd in patients who converted from MRD negative to …
Benefit with Isa-VRd/Isa-Rd was observed across key patient subgroups, including older (>70 years) and frail patients. Time …
Seizure onset determination.
Rodin E, Constantino T, Rampp S, Modur P. Rodin E, et al. J Clin Neurophysiol. 2009 Feb;26(1):1-12. doi: 10.1097/WNP.0b013e3181969017. J Clin Neurophysiol. 2009. PMID: 19151615 Review.
Inasmuch as ISA and HFA have considerably smaller electrical fields than the conventional frequencies they may better define seizure onset than might be possible otherwise. It is recommended that to determine the clinical value of ISA and HFA for epilepsy surgery, r …
Inasmuch as ISA and HFA have considerably smaller electrical fields than the conventional frequencies they may better define seizure …
Montanide ISA-51: a promising adjuvant in cancer vaccine immunotherapy.
Nan L, Zhang X, Ziyi L, Li S, Xia N. Nan L, et al. Expert Rev Vaccines. 2025 Dec;24(1):958-971. doi: 10.1080/14760584.2025.2576234. Epub 2025 Oct 22. Expert Rev Vaccines. 2025. PMID: 41102132 Free article. Review.
AREAS COVERED: This review examines the current applications of Montanide ISA-51 in cancer vaccines, explores its immunoregulatory mechanisms, highlights the challenges in its use as a vaccine adjuvant, and proposes avenues for future optimization. ...These insights will a …
AREAS COVERED: This review examines the current applications of Montanide ISA-51 in cancer vaccines, explores its immunoregulatory me …
ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
[No authors listed] [No authors listed] Drugs R D. 2007;8(2):103-12. doi: 10.2165/00126839-200708020-00005. Drugs R D. 2007. PMID: 17324008 Review.
Under the terms of the agreement, Lonza will manufacture sufficient quantities of trans-ISA 247 in a GMP environment for use in the company's upcoming clinical trials. Isotechnika completed the phase III SPIRIT trial of ISA 247 for psoriasis in Canada. ...Half of th …
Under the terms of the agreement, Lonza will manufacture sufficient quantities of trans-ISA 247 in a GMP environment for use in the c …
Isoalantolactone: a review on its pharmacological effects.
Yang G, Yang L, Xu F. Yang G, et al. Front Pharmacol. 2024 Sep 23;15:1453205. doi: 10.3389/fphar.2024.1453205. eCollection 2024. Front Pharmacol. 2024. PMID: 39376605 Free PMC article. Review.
The anticancer effects of ISA involve proliferation inhibition, ROS overproduction, apoptosis induction and cell cycle arrest. Through inhibiting NF-kappaB signaling, ISA exerts its anti-inflammatory effects which are involved in the neuroprotection of ISA. . …
The anticancer effects of ISA involve proliferation inhibition, ROS overproduction, apoptosis induction and cell cycle arrest. Throug …
Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing.
Zhou J, Xu B, Zheng Y, Huang H, Wei Z, Chen S, Huang W, Liu M, Zhang Y, Wu X. Zhou J, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2379-2389. doi: 10.1093/jac/dkae240. J Antimicrob Chemother. 2024. PMID: 39086118 Free article.
For paediatric patients aged 1 to less than 6 years old, a weight-based dosing regimen (5.38 mg/kg) of ISA was suggested. CONCLUSION: The predicted value aligns with observations, suggesting ISA's potential predictability in PK profiles for other populations. The re …
For paediatric patients aged 1 to less than 6 years old, a weight-based dosing regimen (5.38 mg/kg) of ISA was suggested. CONCLUSION: …
Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.
Silva LA, Souza MF, Carvalho TP, Santana CH, Guedes AC, Oliveira JBS, de Lima PA, Nogueira PRA, de Mello Brandão H, da Paixão TA, Santos RL. Silva LA, et al. PLoS One. 2024 Apr 4;19(4):e0298117. doi: 10.1371/journal.pone.0298117. eCollection 2024. PLoS One. 2024. PMID: 38573916 Free PMC article.
However, Montanide ISA 61 induced less intense reactogenicity when compared to alginate/chitosan. Furthermore, gamma-irradiated B. ovis with Montanide ISA 61 induced higher levels of IgG2b an important marker of cellular immune response. In conclusion, Montanide …
However, Montanide ISA 61 induced less intense reactogenicity when compared to alginate/chitosan. Furthermore, gamma-irradiated B. ov …
16,776 results
You have reached the last available page of results. Please see the User Guide for more information.